AKEBIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 Feb 2026 10:10:40 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

17 Feb 2026 10:52:51 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 Feb 2026 13:06:39 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 Jan 2026 09:46:18 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 Jan 2026 10:03:31 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

12 Jan 2026 09:46:26 By NetDania Notify

Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook

12 Jan 2026 08:00:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

06 Jan 2026 08:00:01 By Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Jan 2026 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

02 Dec 2025 10:42:52 By NetDania Notify

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Dec 2025 16:05:00 By Nasdaq GlobeNewswire

Akebia Announces Establishment of Rare Kidney Disease Pipeline

01 Dec 2025 07:00:00 By Nasdaq GlobeNewswire

Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

24 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

21 Nov 2025 09:45:05 By NetDania Notify

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

10 Nov 2025 07:00:01 By Nasdaq GlobeNewswire

Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

06 Nov 2025 18:30:00 By Nasdaq GlobeNewswire

Akebia Therapeutics to Present at Upcoming Investor Conferences

04 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Nov 2025 16:05:00 By Nasdaq GlobeNewswire

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

30 Oct 2025 08:00:01 By Nasdaq GlobeNewswire

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

28 Oct 2025 16:30:00 By Nasdaq GlobeNewswire